Health-related social needs in HF, removing age from frailty scores, CIED concerns about smartwatches, and more.

Objectives Given the rapidly evolving therapeutic landscape for type 2 diabetes (T2D) and chronic kidney disease (CKD), this study aimed to characterise the clinical profiles and real-world outcomes ...

Objective Patients with atrial fibrillation (AF) frequently have multiple comorbidities that increase the risk of hospitalisation and contribute to higher mortality. However, studies examining the ...

Background Depression is a risk factor and complication of coronary artery disease (CAD) that is associated with poor ...

Background Multiple long-term conditions (MLTCs) are common among individuals with heart failure (HF); however, the influence ...

Moving cannabis to a category of drugs that includes some common medicines will have implications for research, businesses ...

Patients who start their blood pressure treatment with angiotensin receptor blocker (ARB) drugs continue with the same ...

A comprehensive ingredient-level analysis of the nine-compound liquid dropper supplement, examining scientific research, ...

The FDA has approved narsoplimab (Yartemlea) as the first treatment for hematopoietic stem cell transplant (HSCT)-associated ...

Patients who start their blood pressure treatment with ARB drugs continue with the same medicine to a greater extent than ...

More than 1,200 ‘slap on the wrist’ warnings were handed out by police last year to people caught with Class A drugs - allowing them to escape without punishment. Ministers were condemned for forcing ...

Replacing aspirin with a P2Y12 inhibitor soon after coronary stenting is tied to a higher ischemic risk than dual antiplatelet therapy in the first 30 days, but not later, in acute coronary syndrome.